drugset / Trial / NCT01568450

A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

NCT01568450

Phase 1 Completed 24 enrolled GL Pharm Tech Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this clinical trial is to compare the pharmacokinetic characteristics of GL2907 XL 20mg tablet and Oxycontin CR 10mg tablet. GL2907 XL 20mg tablet is controlled released formulation which is made by GL Pharm Tech.

Timeline

Start
2012-03
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified 10 mg
Comparator Oxycodone Other / unclassified 20 mg

Indications

No indication recorded.